Abstract
The Wnt signaling pathways are well known for having several pivotal roles during embryonic development. However, the same developmental signaling pathways also present key roles in cancer initiation and progression. In this chapter, several issues regarding the roles of both canonical and non-canonical Wnt signaling pathways in cancer will be explored, mainly concerning their role in the maintenance of cancer stemness, in the metabolism reprograming of cancer cells and in the modulation of the tumor microenvironment. The role of Wnt signaling cascades in the response of cancer cells to anti-cancer treatments will be also discussed, as well as its potential therapeutic targeting during cancer treatment. Collectively, increasing evidence has been supporting pivotal roles of Wnt signaling in several features of cancer biology, however; a lot is still to be elucidated.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler PN (2002) Planar signaling and morphogenesis in drosophila. Dev Cell 2:525–535. https://doi.org/10.1016/S1534-5807(02)00176-4
Adler PN, Lee H (2001) Frizzled signaling and cell–cell interactions in planar polarity. Curr Opin Cell Biol 13:635–640. https://doi.org/10.1016/S0955-0674(00)00263-5
Alam MM, Lal S, FitzGerald KE, Zhang L (2016) A holistic view of cancer bioenergetics: mitochondrial function and respiration play fundamental roles in the development and progression of diverse tumors. Clin Transl Med 5:1–14. https://doi.org/10.1186/s40169-016-0082-9
Albrecht LV, Bui MH, De Robertis EM (2019) Canonical Wnt is inhibited by targeting one-carbon metabolism through methotrexate or methionine deprivation. Proc Natl Acad Sci 116:2987–2995. https://doi.org/10.1073/pnas.1820161116
Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13:11–26. https://doi.org/10.1038/nrc3419
Bao R, Christova T, Song S et al (2012) Inhibition of tankyrases induces axin stabilization and blocks Wnt signalling in breast cancer cells. PLoS One 7:1–9. https://doi.org/10.1371/journal.pone.0048670
Barker HE, Paget JTE, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409–425. https://doi.org/10.1038/nrc3958
Batlle E, Clevers H (2017) Cancer stem cells revisited. Nat Med 23:1124–1134. https://doi.org/10.1038/nm.4409
Biechele TL, Kulikauskas RM, Toroni RA et al (2012) Wnt/β-catenin signaling and AXIN1 regulate apoptosis mediated by inhibition of BRAFV600E kinase in human melanoma. Sci Signal 5:1–26. https://doi.org/10.1126/scisignal.2002274.Wnt/
Bogaerts E, Heindryckx F, Vandewynckel YP et al (2014) The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (review). Int J Oncol 44:1015–1022. https://doi.org/10.3892/ijo.2014.2286
Cadigan KM, Nusse R (1997) Wnt signaling: a common theme in animal development. Genes Dev 11:3286–3305. https://doi.org/10.1101/gad.11.24.3286
Carreira-Barbosa F, Kajita M, Morel V et al (2009) Flamingo regulates epiboly and convergence/extension movements through cell cohesive and signalling functions during zebrafish gastrulation. Development 136:383–392. https://doi.org/10.1242/dev.026542
Castañeda-Patlán MC, Fuentes-García G, Robles-Flores M (2018) Wnt signaling as a master regulator of immune tolerance in a tumor microenvironment. In: Ray S (ed) Cell signalling-thermodynamics and molecular control. IntechOpen
Chen H, Xu L, Li L et al (2018) Inhibiting the CD8+ T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance. Sci Rep 8:1–10. https://doi.org/10.1038/s41598-018-30417-6
Chen G, Gao C, Gao X et al (2019) Wnt/β-catenin pathway activation mediates adaptive resistance to BRAF inhibition in colorectal cancer. Mol Cancer Ther 17:806–813. https://doi.org/10.1158/1535-7163.MCT-17-0561.Wnt/
Choi S-C, Han J-K (2002) Xenopus Cdc42 regulates convergent extension movements during gastrulation through Wnt/Ca2+ signaling pathway. Dev Biol 244:342–357. https://doi.org/10.1006/dbio.2002.0602
Corda G, Sala A (2017) Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage. Oncogene 6:1–6. https://doi.org/10.1038/oncsis.2017.69
Cori CA, Cori GT (1925) The carbohydrate metabolism of tumours. J Biol Chem 65:397–405
Cramer T, Schmitt C (eds) (2016) Metabolism in cancer. Springer
Da Forno PD, Pringle JH, Hutchinson P et al (2008) WNT5A expression increases during melanoma progression and correlates with outcome. Clin Cancer Res 14:5825–5832. https://doi.org/10.1158/1078-0432.CCR-07-5104
Dejmek J, Dejmek A, Säfholm A et al (2005) Wnt-5a protein expression in primary dukes B colon cancers identifies a subgroup of patients with good prognosis. Cancer Res 65:9142–9146. https://doi.org/10.1158/0008-5472.CAN-05-1710
Fan Y, Shen B, Tan M et al (2014) Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J 281:1750–1758. https://doi.org/10.1111/febs.12737
Fior R, Zilhão R (eds) (2019) Molecular and cell biology of cancer. Springer
Freimund AE, Beach JA, Christie EL, Bowtell DDL (2018) Mechanisms of drug resistance in high-grade serous ovarian cancer. Hematol Oncol Clin North Am 32:983–996. https://doi.org/10.1016/j.hoc.2018.07.007
Frenquelli M, Caridi N, Antonini E et al (2019) The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation. Leukemia:1–14. https://doi.org/10.1038/s41375-019-0486-9
Gilbert SF, Barresi MJF (2019) Developmental biology, 12th edn. Sinauer Associates, Inc, Sunderland
Gillies RJ, Verduzco D, Gatenby RA (2012) Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat Rev Cancer 12:487–493. https://doi.org/10.1038/nrc3298
Gu H, Huang T, Shen Y et al (2018) Reactive oxygen species-mediated tumor microenvironment transformation: the mechanism of radioresistant gastric cancer. Oxidative Med Cell Longev 2018:1–8. https://doi.org/10.1155/2018/5801209
Guppy M, Leedman P, Zu X, Russell V (2002) Contribution by different fuels and metabolic pathways to the total ATP turnover of proliferating MCF-7 breast cancer cells. Biochem J 364:309–315. https://doi.org/10.1042/bj3640309
Gupta S, Roy A, Dwarakanath BS (2017) Metabolic cooperation and competition in the tumor microenvironment: implications for therapy. Front Oncol 7:1–24. https://doi.org/10.3389/fonc.2017.00068
Habas R, Kato Y, He X (2001) Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel formin homology protein Daam1. Cell 107:843–854. https://doi.org/10.1016/S0092-8674(01)00614-6
Han P, Ji X, Zhang M, Gao L (2018) Upregulation of lncRNA LINC00473 promotes radioresistance of HNSCC cells through activating Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci 22:7305–7313. https://doi.org/10.26355/eurrev_201811_16267
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Harb J, Lin PJ, Hao J (2019) Recent development of Wnt signaling pathway inhibitors for cancer therapeutics. Curr Oncol Rep 21:1–9. https://doi.org/10.1007/s11912-019-0763-9
Hayes JD, Dinkova-Kostova AT (2014) The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 39:199–218. https://doi.org/10.1016/j.tibs.2014.02.002
Huelsken J, Birchmeier W (2001) New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 11:547–553. https://doi.org/10.1016/S0959-437X(00)00231-8
Ishitani T, Kishida S, Hyodo-Miura J et al (2003) The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca2+ pathway to antagonize Wnt/β-catenin signaling. Mol Cell Biol 23:131–139. https://doi.org/10.1128/MCB.23.1.131-139.2003
Jeong W-J, Ro EJ, Choi K-Y (2018) Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway. NPJ Precis Oncol 2:1–10. https://doi.org/10.1038/s41698-018-0049-y
Katoh M (2017) Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (review). Int J Oncol 51:1357–1369. https://doi.org/10.3892/ijo.2017.4129
Katoh M, Katoh M (2017) Molecular genetics and targeted therapy of WNT-related human diseases (review). Int J Mol Med 40:587–606. https://doi.org/10.3892/ijmm.2017.3071
Kinoshita N, Iioka H, Miyakoshi A, Ueno N (2003) PKCδ is essential for dishevelled function in a noncanonical Wnt pathway that regulates Xenopus convergent extension movements. Genes Dev 17:1663–1676. https://doi.org/10.1101/gad.1101303
Kozovska Z, Gabrisova V, Kucerova L (2014) Colon cancer: cancer stem cells markers, drug resistance and treatment. Biomed Pharmacother 68:911–916. https://doi.org/10.1016/j.biopha.2014.10.019
Krishnamurthy N, Kurzrock R (2018) Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev 62:50–60. https://doi.org/10.1016/j.ctrv.2017.11.002
Kurayoshi M, Oue N, Yamamoto H et al (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66:10439–10448. https://doi.org/10.1158/0008-5472.CAN-06-2359
Laurent-Puig P, Zucman-Rossi J (2006) Genetics of hepatocellular tumors. Oncogene 25:3778–3786. https://doi.org/10.1038/sj.onc.1209547
Lejeune S, Huguet EL, Hamby A et al (1995) Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res 1:215–222
Luke JJ, Bao R, Sweis RF et al (2019) WNT/β-catenin pathway activation correlates with immune exclusion across human cancers. Clin Cancer Res 25:3074–3083. https://doi.org/10.1158/1078-0432.CCR-18-1942
Luo M, Wu C, Guo E et al (2019a) FOXO3a knockdown promotes radioresistance in nasopharyngeal carcinoma by inducing epithelial-mesenchymal transition and the Wnt/β-catenin signaling pathway. Cancer Lett 455:26–35. https://doi.org/10.1016/j.canlet.2019.04.019
Luo Y, Barrios-Rodiles M, Gupta GD et al (2019b) Atypical function of a centrosomal module in WNT signalling drives contextual cancer cell motility. Nat Commun 10:1–20. https://doi.org/10.1038/s41467-019-10241-w
Lyou Y, Chen G, Waterman M (2018) Abstract 385: HIF1A can regulate Wnt signaling in human colon cancer cells. In: AACR annual meeting 2018 April 14–18. Chicago, pp 385–385
Maccalli C, Todaro M, Ferrone S (eds) (2019) Cancer stem cell resistance to targeted therapy. Springer
Macheda ML, Stacker SA (2008) Importance of Wnt signaling in the tumor stroma microenvironment. Curr Cancer Drug Targets 8:454–465
Mehta K, Siddik ZH (eds) (2009) Drug resistance in cancer cells. Springer
Meyer IS, Jungmann A, Dieterich C et al (2017) The cardiac microenvironment uses non-canonical WNT signaling to activate monocytes after myocardial infarction. EMBO Mol Med 9:1279–1293. https://doi.org/10.15252/emmm.201707565
Miyagi C, Yamashita S, Ohba Y et al (2004) STAT3 noncell-autonomously controls planar cell polarity during zebrafish convergence and extension. J Cell Biol 166:975–981. https://doi.org/10.1083/jcb.200403110
Mo Y, Wang Y, Zhang L et al (2019) The role of Wnt signaling pathway in tumor metabolic reprogramming. J Cancer 10:3789–3797. https://doi.org/10.7150/jca.31166
Moharil R, Dive A, Khandekar S, Bodhade A (2017) Cancer stem cells: an insight. J Oral Maxillofac Pathol 21:463–463. https://doi.org/10.4103/jomfp.JOMFP_132_16
Morgan R, Ankrah R, El-Tanani S et al (2017) Wnt Signaling as a therapeutic target in cancer and metastasis. In: Introduction to cancer metastasis. pp 375–394
Murphy K, Weaver C (2016) Janeway’S immunobiology, 9th edn. Garland Science/Taylor & Francis Group, LLC, New York
Niiro E, Morioka S, Iwai K et al (2018) Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (review). Biomed Rep:215–223. https://doi.org/10.3892/br.2018.1045
Ojalvo LS, Whittaker CA, Condeelis JS, Pollard JW (2010) Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol 184:702–712. https://doi.org/10.1038/mp.2011.182.doi
Olsen JJ, Pohl SO-G, Deshmukh A et al (2017) The role of Wnt signalling in angiogenesis. Clin Biochem Rev 38:131–142. https://doi.org/10.1161/CIRCRESAHA.116.310498
Pai SG, Carneiro BA, Mota JM et al (2017) Wnt/beta-catenin pathway: modulating anticancer immune response. J Hematol Oncol 10:1–12. https://doi.org/10.1186/s13045-017-0471-6
Pai VC, Hsu C-C, Chan T-S et al (2019) ASPM promotes prostate cancer stemness and progression by augmenting Wnt−Dvl-3−β-catenin signaling. Oncogene 38:1340–1353. https://doi.org/10.1038/s41388-018-0497-4
Palacios J, Gamallo C (1998) Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 58:1344–1347
Pate KT, Stringari C, Sprowl-Tanio S et al (2014) Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J 33:1454–1473. https://doi.org/10.15252/embj.201488598
Peng Y, Zhang X, Feng X et al (2017) The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer. Oncotarget 8:14089–14106. https://doi.org/10.18632/oncotarget.12923
Penzo-Mendèz A, Umbhauer M, Djiane A et al (2003) Activation of Gβγ signaling downstream of Wnt-11/Xfz7 regulates Cdc42 activity during Xenopus gastrulation. Dev Biol 257:302–314. https://doi.org/10.1016/S0012-1606(03)00067-8
Pinyol R, Sia D, Llovet JM (2019) Immune exclusion-WNT/CTNNB1 class predicts resistance to immunotherapies in HCC. Clin Cancer Res 25:2021–2023. https://doi.org/10.1158/1078-0432.CCR-18-3778
Potter M, Newport E, Morten KJ (2016) The Warburg effect: 80 years on. Biochem Soc Trans 44:1499–1505. https://doi.org/10.1042/bst20160094
Reis M, Czupalla CJ, Ziegler N et al (2012) Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J Exp Med 209:1611–1627. https://doi.org/10.1084/jem.20111580
Rodríguez-Enríquez S, Torres-Márquez ME, Moreno-Sánchez R (2000) Substrate oxidation and ATP supply in AS-30D hepatoma cells. Arch Biochem Biophys 375:21–30. https://doi.org/10.1006/abbi.1999.1582
Rodríguez-Enríquez S, Vital-González PA, Flores-Rodríguez FL et al (2006) Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. Toxicol Appl Pharmacol 215:208–217. https://doi.org/10.1016/j.taap.2006.02.005
Rycaj K, Tang DG (2015) Cell-of-origin of cancer versus cancer stem cells: assays and interpretations. Cancer Res 75:4003–4011. https://doi.org/10.1158/0008-5472.CAN-15-0798
Saretzki G (2014) Extra-telomeric functions of human telomerase: cancer, mitochondria and oxidative stress. Curr Pharm Des 20:6386–6403. https://doi.org/10.2174/1381612820666140630095606
Satoh S, Daigo Y, Furukawa Y et al (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245–250. https://doi.org/10.1038/73448
Semenza GL (2012) Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 33:207–214. https://doi.org/10.1016/j.tips.2012.01.005
Senni N, Savall M, Cabrerizo Granados D et al (2019) Β-catenin-activated hepatocellular carcinomas are addicted to fatty acids. Gut 68:322–334. https://doi.org/10.1136/gutjnl-2017-315448
Sheldahl LC, Slusarski DC, Pandur P et al (2003) Dishevelled activates Ca2+ flux, PKC, and CamKII in vertebrate embryos. J Cell Biol 161:769–777. https://doi.org/10.1083/jcb.200211094
Sherwood V (2015) WNT signaling: an emerging mediator of cancer cell metabolism? Mol Cell Biol 35:2–10. https://doi.org/10.1128/MCB.00992-14
Slusarski DC, Corces VG, Moon RT (1997) Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390:410–413. https://doi.org/10.1038/37138
Son B, Lee S, Youn H et al (2017) The role of tumor microenvironment in therapeutic resistance. Oncotarget 8:3933–3945. https://doi.org/10.18632/oncotarget.13907
Staal FJT, Famili F, Perez LG, Pike-Overzet K (2016) Aberrant Wnt signaling in leukemia. Cancers (Basel) 8:1–15. https://doi.org/10.3390/cancers8090078
Steinhart Z, Angers S (2018) Wnt signaling in development and tissue homeostasis. Development 145:1–8. https://doi.org/10.1242/dev.146589
Stewart DJ, Chang DW, Ye Y et al (2014) Wnt signaling pathway pharmacogenetics in non-small cell lung cancer. Pharmacogenomics J 14:509–522. https://doi.org/10.1038/tpj.2014.21
Su H-Y, Lai H-C, Lin Y-W et al (2010) Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway. Int J Cancer 127:555–567. https://doi.org/10.1002/ijc.25083
Tada M, Concha ML (2001) Vertebrate gastrulation: calcium waves orchestrate cell movements. Curr Biol 11:R470–R472. https://doi.org/10.1016/S0960-9822(01)00284-6
Tan Z, Song L, Wu W et al (2018) TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2. Oncogene 37:5403–5415. https://doi.org/10.1038/s41388-018-0344-7
Tejeda-Muñoz N, Albrecht LV, Bui MH, De Robertis EM (2019) Wnt canonical pathway activates macropinocytosis and lysosomal degradation of extracellular proteins. Proc Natl Acad Sci 116:10402–10411. https://doi.org/10.1073/pnas.1903506116
VanderVorst K, Dreyer CA, Konopelski SE et al (2019) Wnt/PCP signaling contribution to carcinoma collective cell migration and metastasis. Cancer Res 79:1719–1729. https://doi.org/10.1158/0008-5472.CAN-18-2757
Vangipuram SD, Buck SA, Lyman WD (2012) Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line. Tumor Biol 33:2173–2183. https://doi.org/10.1007/s13277-012-0478-0
Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225–239. https://doi.org/10.1007/s10555-007-9055-1
Veeman MT, Slusarski DC, Kaykas A et al (2003) Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Chem Biol 10:53–60. https://doi.org/10.1016/s0960-9822(03)00240-9
Vergara D, Stanca E, Guerra F et al (2017) Β-catenin knockdown affects mitochondrial biogenesis and lipid metabolism in breast cancer cells. Front Physiol 8:1–17. https://doi.org/10.3389/fphys.2017.00544
Viale A, Corti D, Draetta GF (2015) Tumors and mitochondrial respiration: a neglected connection. Cancer Res 75:3685–3686. https://doi.org/10.1158/0008-5472.CAN-15-0491
Vinson CR, Conover S, Adler PN (1989) A Drosophila tissue polarity locus encodes a protein containing seven potential transmembrane domains. Nature 338:263–264. https://doi.org/10.1038/338263a0
Vona-Davisa L, Gibsona LF (2013) Adipocytes as a critical component of the tumor microenvironment. Leuk Res 37:483–484. https://doi.org/10.1016/j.leukres.2013.01.007
Wallingford JB, Ewald AJ, Harland RM, Fraser SE (2001) Calcium signaling during convergent extension in Xenopus. Curr Biol 11:652–661. https://doi.org/10.1016/S0960-9822(01)00201-9
Wang L, Liu L, Chen Y et al (2018) Correlation between adenosine triphosphate (ATP)-binding cassette transporter G2 (ABCG2) and drug resistance of esophageal cancer and reversal of drug resistance by artesunate. Pathol – Res Pract 214:1467–1473. https://doi.org/10.1016/j.prp.2018.08.001
Warburg O (1956) On the origin of cancer cells. Science 123:309–314. https://doi.org/10.1126/science.123.3191.309
Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519–530. https://doi.org/10.1085/jgp.8.6.519
Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell 21:297–308. https://doi.org/10.1016/j.ccr.2012.02.014
Wickström M, Dyberg C, Milosevic J et al (2015) Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun 6:1–10. https://doi.org/10.1038/ncomms990
Wils LJ, Bijlsma MF (2018) Epigenetic regulation of the hedgehog and Wnt pathways in cancer. Crit Rev Oncol Hematol 121:23–44. https://doi.org/10.1016/j.critrevonc.2017.11.013
Winklbauer R, Medina A, Swain RK, Steinbeisser H (2001) Frizzled-7 signalling controls tissue separation during Xenopus gastrulation. Nature 413:856–860. https://doi.org/10.1038/35101621
Xiang J, Hu Q, Qin Y et al (2018) TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancer. Cell Death Dis 9:1–14. https://doi.org/10.1038/s41419-018-0367-6
Xu W, Zhou W, Cheng M et al (2017) Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma. Sci Rep 7:1–13
Yamashita S, Miyagi C, Carmany-Rampey A et al (2002) Stat3 controls cell movements during zebrafish gastrulation. Dev Cell 2:363–375. https://doi.org/10.1016/S1534-5807(02)00126-0
Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36:1461–1473. https://doi.org/10.1038/onc.2016.304
Zhan T, Ambrosi G, Wandmacher AM et al (2019) MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun 10:2197. https://doi.org/10.1038/s41467-019-09898-0
Zhang B, Wu J, Cai Y et al (2019) TCF7L1 indicates prognosis and promotes proliferation through activation of Keap1/NRF2 in gastric cancer. Acta Biochim Biophys Sin Shanghai 51:375–385. https://doi.org/10.1093/abbs/gmz015
Zhao Y, Yi J, Tao L et al (2018) Wnt signaling induces radioresistance through upregulating HMGB1 in esophageal squamous cell carcinoma. Cell Death Dis 9:1–15. https://doi.org/10.1038/s41419-018-0466-4
Zoico E, Darra E, Rizzatti V et al (2018) Role of adipose tissue in melanoma cancer microenvironment and progression. Int J Obes 42:344–352. https://doi.org/10.1038/ijo.2017.21
Zurawel RH, Chiappa SA, Allen C, Raffel C (1998) Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res 58:896–899
Acknowledgments
The authors acknowledge iNOVA4Health – UID/Multi/04462/2013, a program financially supported by Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência, through national funds and co-funded by FEDER under the PT2020 Partnership Agreement.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Carreira-Barbosa, F., Nunes, S.C. (2020). Wnt Signaling: Paths for Cancer Progression. In: Serpa, J. (eds) Tumor Microenvironment . Advances in Experimental Medicine and Biology, vol 1219. Springer, Cham. https://doi.org/10.1007/978-3-030-34025-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-34025-4_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34024-7
Online ISBN: 978-3-030-34025-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)